Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,843,174
-$88,772 QoQ
Shares Held
14,589
+5.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#860
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avidian Wealth Enterprises, LLC holds $46,072,826 across 12 Drug Manufacturers - General names. GILD ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,670 | $10,399,058 | |
| 2 | JNJ |
Johnson & Johnson
|
38,004 | $9,651,875 | |
| 3 | ABBV |
AbbVie Inc.
|
35,331 | $8,890,692 | |
| 4 | AMGN |
Amgen Inc
|
13,323 | $4,824,524 | |
| 5 | MRK |
Merck & Co., Inc.
|
33,988 | $4,367,458 | |
| 6 | PFE |
Pfizer Inc
|
79,424 | $1,912,529 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
14,589 | $1,843,174 | |
| 8 | NVO |
Novo Nordisk A S
|
31,634 | $1,516,533 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,843,174 | 14,589 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,931,946 | 13,862 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,356,767 | 11,054 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,171,494 | 10,554 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,113,578 | 10,044 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,084,307 | 9,677 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $847,310 | 9,173 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $722,030 | 8,612 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $569,600 | 8,302 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $493,778 | 6,741 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $660,069 | 8,148 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $591,201 | 7,889 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $623,727 | 8,093 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $827,044 | 9,968 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $856,439 | 9,976 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $589,694 | 9,559 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $686,585 | 11,108 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $592,478 | 9,966 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $672,295 | 9,259 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $645,693 | 9,244 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $593,091 | 8,613 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $565,512 | 8,750 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $550,615 | 9,451 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $570,352 | 9,026 | Shares | Sole | 2021-02-03 | |
| 2020-06-30 | $440,635 | 5,727 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $338,513 | 4,528 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||